MetLife Investment Management LLC Has $958,000 Position in Omnicell, Inc. $OMCL

MetLife Investment Management LLC reduced its holdings in Omnicell, Inc. (NASDAQ:OMCL) by 1.5% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 27,414 shares of the company’s stock after selling 407 shares during the quarter. MetLife Investment Management LLC’s holdings in Omnicell were worth $958,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Point72 Hong Kong Ltd acquired a new stake in shares of Omnicell in the fourth quarter valued at about $101,000. AlphaQuest LLC grew its position in shares of Omnicell by 79.0% in the first quarter. AlphaQuest LLC now owns 6,400 shares of the company’s stock valued at $224,000 after purchasing an additional 2,824 shares during the last quarter. New Age Alpha Advisors LLC acquired a new stake in shares of Omnicell in the first quarter valued at about $233,000. EntryPoint Capital LLC grew its position in shares of Omnicell by 21.6% in the first quarter. EntryPoint Capital LLC now owns 6,671 shares of the company’s stock valued at $233,000 after purchasing an additional 1,184 shares during the last quarter. Finally, Occudo Quantitative Strategies LP acquired a new stake in shares of Omnicell in the fourth quarter valued at about $286,000. 97.70% of the stock is owned by institutional investors and hedge funds.

Omnicell Trading Down 3.0%

Shares of OMCL opened at $32.11 on Friday. Omnicell, Inc. has a 12-month low of $22.66 and a 12-month high of $55.74. The company has a quick ratio of 1.24, a current ratio of 1.42 and a debt-to-equity ratio of 0.13. The firm has a market capitalization of $1.47 billion, a price-to-earnings ratio of 64.22, a P/E/G ratio of 7.23 and a beta of 0.82. The stock’s 50-day moving average price is $30.44 and its 200 day moving average price is $31.37.

Omnicell (NASDAQ:OMCL) last issued its quarterly earnings results on Thursday, July 31st. The company reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.30 by $0.15. The firm had revenue of $290.56 million for the quarter, compared to analyst estimates of $275.57 million. Omnicell had a return on equity of 4.27% and a net margin of 2.01%.The company’s quarterly revenue was up 5.0% compared to the same quarter last year. During the same period in the previous year, the company posted $0.51 earnings per share. Omnicell has set its FY 2025 guidance at 1.400-1.650 EPS. Q3 2025 guidance at 0.300-0.370 EPS. As a group, research analysts predict that Omnicell, Inc. will post 1.09 earnings per share for the current year.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the company. Piper Sandler lowered their price target on Omnicell from $57.00 to $55.00 and set an “overweight” rating on the stock in a research report on Monday, August 11th. Wall Street Zen downgraded Omnicell from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 9th. Bank of America boosted their price target on Omnicell from $30.00 to $34.00 and gave the company a “neutral” rating in a research note on Friday, May 23rd. Finally, Wells Fargo & Company boosted their price target on Omnicell from $37.00 to $40.00 and gave the company an “overweight” rating in a research note on Monday, July 21st. Four investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, Omnicell has a consensus rating of “Moderate Buy” and an average target price of $46.71.

Omnicell Company Profile

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.